Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CYTHW - Cyclo Therapeutics Inc - Warrants (14/11/2025)


Previous close
0.052
0   0%

Share volume: 651
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$0.05
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
10.09%
1 Month
-41.45%
3 Months
-48.48%
6 Months
-58.32%
1 Year
-55.59%
2 Year
-80.18%
Key data
Stock price
$0.05
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.05 - $0.38
52 WEEK CHANGE
-$0.56
MARKET CAP 
21.456 M
YIELD 
N/A
SHARES OUTSTANDING 
2.300 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,751
AVERAGE 30 VOLUME 
$2,734
Company detail
CEO:
Region: US
Website: ctd-holdings.com
Employees: 16
IPO year: -
Issue type:
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

cyclodextrin technologies development, inc. (ctd), the "company"​, was organized as a florida corporation on august 9, 1990 with operations beginning july, 1992. in may of 1994 the company became a fully reporting public company listed on the otc bb under the symbol ctdi. in 2000, the company altered its corporate structure to a holding company with subsidiary companies. the otc bb symbol was changed to ctdh. ctd holdings, inc. (the "company"​) was originally formed to market and sell cyclodextrins and related products to the food, pharmaceutical, and other industries; it also provided consulting services related to cyclodextrin technology. ctdh, as a holding company, will acquire, create, and invest in companies that will develop, market, and/or sell products containing cyclodextrins. the company currently operates four wholly owned subsidiaries: ctd, inc.; nanosonic products, inc.; sphingo biotech, inc.; and ferrazo environmental technologies, inc.

Recent news